First Trust Indxx Medical Devices ETF Rating $19.29 +0.10 (+0.52%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock First Trust Indxx Medical Devices ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MDEV Aggregate RatingModerate Buy 2.57Holdings in MDEV have an aggregate rating of Moderate Buy based on 253 analyst ratings issued in the past year covering 15 companies (34.6% of the portfolio).MDEV Aggregate Price Target$19.29High Prediction$19.29Average Prediction$19.29Low Prediction$19.29Holdings in MDEV have an aggregate price target of $19.29 and a range of $19.29 to $19.29 covering 15 companies (34.6% of the portfolio).MDEV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Indxx Medical Devices ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 MDEV Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.78%WSTWest Pharmaceutical Services$328.61-7.6%3.862 of 5 stars3.00$363.17 10.5%15Trending NewsEarnings ReportDividend AnnouncementHigh Trading Volume2.63%LIVNLivaNova$78.19-0.5%2.4303 of 5 stars2.73$81.38 4.1%11News CoverageAnalyst Upgrade2.62%BAXBaxter International$22.40+3.4%1.313 of 5 stars1.85$19.91 -11.1%13News CoverageUpcoming Earnings2.52%RVTYRevvity$110.56-2.3%2.2187 of 5 stars2.13$108.92 -1.5%16News CoveragePositive News2.35%EWEdwards Lifesciences$82.67-1.4%4.2085 of 5 stars2.75$99.55 20.4%24Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume2.35%WATWaters$374.49-2.1%2.786 of 5 stars2.71$401.60 7.2%21News CoveragePositive News2.33%AAgilent Technologies$138.65-0.8%4.6967 of 5 stars2.89$159.35 14.9%19News CoveragePositive NewsUpcoming EarningsAnalyst Downgrade2.28%DXCMDexCom$71.54+1.5%4.1739 of 5 stars2.89$85.36 19.3%27Upcoming Earnings2.26%TFXTeleflex$131.86+0.5%3.3639 of 5 stars2.45$148.00 12.2%11News Coverage2.13%BIOBio-Rad Laboratories$313.78-0.8%0.8754 of 5 stars1.80$303.33 -3.3%5News CoveragePositive News2.10%TMOThermo Fisher Scientific$567.34-0.9%4.4845 of 5 stars2.79$613.05 8.1%24Trending NewsEarnings ReportAnalyst Forecast2.09%MMSIMerit Medical Systems$74.32+1.7%3.8553 of 5 stars2.64$92.80 24.9%11Positive NewsUpcoming EarningsAnalyst Revision2.06%ALGNAlign Technology$167.01-0.7%3.4113 of 5 stars2.67$206.36 23.6%15News CoverageUpcoming EarningsAnalyst Forecast2.06%DHRDanaher$191.87-0.3%4.7327 of 5 stars2.84$228.91 19.3%25Trending NewsEarnings ReportAnalyst ForecastOptions Volume2.00%COOCooper Companies$70.31+0.1%3.2632 of 5 stars2.38$81.85 16.4%16News CoveragePositive News This page (BATS:MDEV) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe comeback story of the century (ticker inside)In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...InvestorPlace | SponsoredControl 100 shares without spending thousands of dollarsWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Indxx Medical Devices ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Indxx Medical Devices ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
